CD8A and myeloid sarcoma: A previous study described an enrichment of CD8+CD20+ T cells in white matter lesions of patients with MS (36), emphasizing the idea that myelin-specific CD8+CD20+ T cells may largely be recruited to the brain parenchyma during inflammation in patients with MS and not reside at the CNS borders.